Apr 26, 2017
By Pharmaceutical Executive Editors
A new report from QuintilesIMS asks, it more advantageous to take a product to market by "Going It Alone" or by partnering with an established pharma company?
Mar 09, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Facing mixed market signals, biotech companies look to rise above the fray in advancing new-wave discoveries to the clinical finish line.
Feb 28, 2017
Pharmaceutical Executive
A panel of biopharma executives responsible for the Latin America business discuss investment, market access, and reimbursement issues in this key regional growth market for the life sciences industry.
Feb 21, 2017
Neil Grubert discusses the key trends in market access this year and beyond.
Feb 10, 2017
Haydn Evans looks at the role of intellectual property (IP) management in protecting pharmaceutical company products.
Feb 09, 2017
Pharmaceutical Executive
Keith Bailey offers a new approach to reviving industry collaborations.
Feb 08, 2017
Pharmaceutical Executive
The key steps to easing rising complexity and cost factors.
Jan 11, 2017
How can Pharma balance the need to access to patient data and still respect patient privacy? One approach is to access patients through third-party online communities, writes Peter Houston.
Dec 18, 2016
Pharmaceutical Executive
In a continent marked by stark differences in governance, growth and market potential, the best bets must be pursued off script.
Dec 12, 2016
Pharmaceutical Executive
How a Manufacturing Excellence program can deliver competitive advantage to a fast-changing global product mix—at lower cost, and with an unexpected workforce dividend to boot.
lorem ipsum